Insomnia Market – Industry Analysis and Forecast (2024-2030)

Insomnia Market size was valued at US$ 5.23 Bn in 2023 and the total revenue is expected to grow at 4.2 % through 2024 to 2030, reaching nearly US$ 6.97 Bn.
Global Insomnia Market Overview:
Insomnia is a sleeping problem that affects people of all ages. Insomnia is also a term used to describe someone who has problems sleeping. This might exist in its own right or in combination with other psychological problems. Insomnia is more common in women than in men, and it is more likely to occur throughout life stages such as pregnancy and after childbirth, as well as the menopausal cycle. The specific origin of sleeplessness, however, remains a secret.To know about the Research Methodology :- Request Free Sample Report
Global Insomnia Market Dynamics:
An increasing in the launch of new sleep-inducing drugs, devices, and treatments is anticipated to drive the insomnia market growth. For example, the Insomnia Clinic in Bloomsbury has developed a new treatment for insomnia. The clinical trials for the Insomnia showed positive results where 80% of the patients displayed remarkable improvements. Likewise, Eisai Inc has developed a drug called lemborexant (dual orexin receptor antagonist), adual orexin receptor antagonist that anticipated to be effective for the treatment of the older population with insomnia. Positive results and low price of devices are predictable to be the major factors promoting demand for devices.

Insomnia therapeutic devices have started gaining traction in developed countries such as Norway, Switzerland, Australia and Ireland. Medical devices have benefits like the fast onset of sleep and longer sleep maintenance among patients who have negative results through drugs. New technical devices like Alpha-Stim AID, Ebb Insomnia Therapy, and Fisher Wallace Stimulator have already received approvals from FDA. The Lemborexant, a novel Orexin Receptor Antagonist (ORA) by Eisai is anticipated to be launched in the early phase during forecast period.

Manufacturers in the Insomnia are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.
Global Insomnia Market Segment Analysis:
The global Insomnia Market is segmented by Treatment Type and Non-pharmacological Treatment.

Based on Treatment Type, the global Insomnia market is segmented into Non-pharmacological Treatment and Pharmacological Treatment. The pharmacological treatment is further sub-segmented into prescription sleep aids and over-the-counter sleep aids. The over-the-counter sleep aids is expected to grow at a highest CAGR of xx% in the global insomnia market during the forecast period. As comparison to prescription sleep medications, due to its easy accessibility and lower cost As per research statistics, utilising over-the-counter sleep medications will save a patient up to USD 47 each week.
Global Insomnia Market Regional Insights:
North America dominate the global Insomnia market during the forecast period 2024-2030. North America held the largest market share xx% in 2023. Asia Pacific without Japan is also expected to be a dominant region for the insomnia market’s growth. The reason for this is attributable to the increasing shift-related work in this region causing numerous sleep disorders. The rising urban population in this region has also driven the market’s expansion. Indonesia, India, and China are expected to be leading regions for the market’s growth in this region. According to Centers for Disease Control and Prevention (CDCP), approximately xx million adults in the United State suffered from insomnia disease. This is a result of the unhealthy lifestyle and rising stress levels among the population. Apart from the U.S., Canada has also highly contributed to the insomnia market’s growth in this region.

The objective of the report is to present a comprehensive analysis of the global Insomnia Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also helps in understanding the global Insomnia Market dynamic, structure by analyzing the market segments and project the global Insomnia Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Insomnia Market make the report investor’s guide.
Global Insomnia Market Scope: Inquire before buying



Global Insomnia Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US$ 5.23 Bn.


Forecast Period 2024 to 2030 CAGR:
4.2%
Market Size in 2030:
US$ 6.97 Bn.


 Segments Covered:
by Treatment Type
Non-Pharmacological Treatment
Pharmacological Treatment
Prescription Sleep Aids
 Over-the-Counter Sleep Aids


by Therapy
Cognitive Behavioral Therapy for Isomnia
Hypnotherapy
Other Alternative Therapies


by Drug Class
Antidepressants
Melatonin Antagonist
Benzodiazepines
Nonbenzodiazepines
Orexin Antagonist
Others


by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies



Global Insomnia Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players
1. Astellas
2. Biocodex S A
3. Consumer Healthcare Inc.
4. Dainippon Sumitomo
5. ECR Pharmaceuticals
6. Eisai Co.
7. Flynn Pharma
8. Johnson and Johnson
9. Meda Consumer Healthcare Inc.
10. Merck and Co. Inc.
11. Neurim
12. Pernix Therapeutics
13. Pfizer Inc
14. Purdue Pharma L.P.
15. Sanofi Pasteur
16. SkyePharma
17. Takeda Pharmaceutical Company
18. Mallinckrodt
19. Galt Pharmaceuticals, LLC.
20. Sumitomo Dainippon Pharma Co., Ltd.
21. Teva Pharmaceutical Industries Ltd.
22. Vanda Pharmaceuticals

Frequently Asked Questions:

1] What segments are covered in Market report?
Ans.The segments covered in Insomnia Market report are based on Prescription Sleep Aids, Over-the-Counter Sleep Aids, and Non-pharmacological Treatment.

2] Which region is expected to hold the highest share in the global Market?
Ans. North America is expected to hold the highest share in the global Insomnia Market.

3] What is the market size of global Market by 2030?
Ans. The market size of global Insomnia Market by 2030 is US $ 6.97 Bn.

4] Who are the top key players in the global Insomnia Market?
Ans. Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, and Eisai Co. are the top key players in the global Insomnia Market.

5] What was the market size of global Insomnia Market in 2023?
Ans.The market size of global Insomnia Market in 2023 was US $ 5.23 Bn.

6] By Non-pharmacological Treatment, What segments are covered in Insomnia Market report?
Ans. The segments covered in Insomnia Market report by Non-pharmacological Treatment, are Cognitive Behavioral Therapy for Insomnia (CBTI), Hypnotherapy and Other Alternative Therapies.